Pepsinogen C

03/01/1995 - "In contrast, there was no significant correlation between serum pepsinogen C and any of the gastritis scores. "
04/01/2022 - "Pepsinogen II in gastritis and Helicobacter pylori infection."
02/01/2016 - "Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention."
11/01/1995 - "In 48 successfully eradicated cases, there was a significant decrease in gastritis score, and was a significant fall in serum pepsinogen II (PG II) level, and was a significant increase in pepsinogen I/II ratio (PG I/II ratio). "
02/01/2016 - "Increased serum pepsinogen II compared to normal serum pepsinogen I seems to indicate the presence of diffuse gastritis without precancerous lesions suitable for eradication of H. "

07/09/2021 - "Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects."
01/01/2014 - "A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. "
01/01/2004 - "Serum pepsinogen II (sPGII) levels are known to increase during Helicobacter pylori infection. "
01/01/2004 - "Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection."
09/01/2008 - "This study was designed to investigate the interaction between pepsinogen C(PGC) insertion/deletion polymorphism and Helicobacter pylori(Hp) infection, together with its different subtype strains, in the development of gastric cancer (GC). "

02/01/1998 - "The higher levels of circulating pepsinogen C found in patients infected with cytotoxic genotypes may reflect the higher degree of inflammation sustained by these strains."
10/01/2013 - "pylori antibody titer and pepsinogen II. Methylation levels of the six CpG islands were consistently increased, and those of the two repetitive elements were consistently decreased in a stepwise manner with the activity of gastric inflammation as represented by serum marker levels. "
01/01/2014 - "Unlike pepsinogen II and pepsinogen I to II ratio that were affected by the severity of inflammation and atrophy in corpus in all groups, pepsinogen I generally did not change. "
03/01/2004 - "Studies included gastric emptying, esophageal manometry, gastric and esophageal pH monitoring as well as measuring serum levels of gastrin, pepsinogen I and pepsinogen II. Helicobacter pylori eradication was associated with a significant change in serum gastrin and pepsinogen levels, consistent with the improvement in mucosal inflammation. "
04/01/2008 - "In addition, 9.2% of atrophy-negative subjects with pepsinogen I of >70 ng/mL and pepsinogen I/II ratio of < or =3.0 (reflecting putative inflammation-based high pepsinogen II level) are at high risk for cancer, particularly diffuse-type cancer, with a cancer incidence rate comparable with atrophy-positive subjects (216 per 100,000 person-years). "

12/01/2014 - "Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor."
01/01/2019 - "Background: Aberrant expression of pepsinogen C (PGC) has been observed in human cancers. "
01/01/2018 - "Pepsinogen C (PGC) decreases gradually during progression of cancer, which makes PGC an ideal negative marker for GC. "
01/01/2017 - "Pepsinogen C expression, regulation and its relationship with cancer."
02/01/2009 - "When we tested these results in the benign prostate tissues from patients with cancer, pepsinogen C maintained the expression pattern. "

03/01/1990 - "Immunolocalization of progastricsin in a histological section of metastatic adenocarcinoma may help to locate the primary site."
03/01/1990 - "Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma."
02/01/2013 - "The threshold level was the rate between pepsinogen I and pepsinogen II can be used as criteria of intensity ofproliferative activity of epithelial cells of adenomas and cells of adenocarcinomas of stomach."
02/01/2013 - "In case of adenomas and adenocarcinomas of stomach the concentration of pepsinogen I and the rate between pepsinogen I and pepsinogen II are in inverse correlation relationship with indicators of proliferative activity of epithelial cells and tumor cells correspondingly. "
09/01/1989 - "We studied circulating levels of pepsinogen A (PGA) and pepsinogen C (PGC) in 179 patients with fundic atrophic gastritis, 29 unselected patients with gastric adenocarcinoma, 15 totally gastrectomized patients, and 50 gastroscopically examined normal controls. "